ATE211765T1 - Neue familie von proteaseinhibitoren und andere biologisch aktive substanzen - Google Patents
Neue familie von proteaseinhibitoren und andere biologisch aktive substanzenInfo
- Publication number
- ATE211765T1 ATE211765T1 AT95937853T AT95937853T ATE211765T1 AT E211765 T1 ATE211765 T1 AT E211765T1 AT 95937853 T AT95937853 T AT 95937853T AT 95937853 T AT95937853 T AT 95937853T AT E211765 T1 ATE211765 T1 AT E211765T1
- Authority
- AT
- Austria
- Prior art keywords
- relates
- biologically active
- inhibitors
- active substances
- protease inhibitors
- Prior art date
Links
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 title abstract 3
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title abstract 3
- 239000013543 active substance Substances 0.000 title 1
- 241000545744 Hirudinea Species 0.000 abstract 2
- 101710115215 Protease inhibitors Proteins 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 239000013598 vector Substances 0.000 abstract 2
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Virology (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP94117053 | 1994-10-28 | ||
| EP95103637 | 1995-03-14 | ||
| PCT/EP1995/004223 WO1996013585A1 (en) | 1994-10-28 | 1995-10-27 | A novel family of protease inhibitors, and other biologic active substances |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE211765T1 true ATE211765T1 (de) | 2002-01-15 |
Family
ID=26135896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95937853T ATE211765T1 (de) | 1994-10-28 | 1995-10-27 | Neue familie von proteaseinhibitoren und andere biologisch aktive substanzen |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6239106B1 (de) |
| EP (1) | EP0789764B1 (de) |
| JP (1) | JP4278175B2 (de) |
| AT (1) | ATE211765T1 (de) |
| AU (1) | AU3870195A (de) |
| CA (1) | CA2203827A1 (de) |
| DE (1) | DE69524971T2 (de) |
| DK (1) | DK0789764T3 (de) |
| ES (1) | ES2171563T3 (de) |
| PT (1) | PT789764E (de) |
| WO (1) | WO1996013585A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0861085T3 (da) | 1995-11-13 | 2005-11-21 | Vitaleech Bioscience N V | Antivirale isolater opnået fra igler |
| AUPO427596A0 (en) * | 1996-12-20 | 1997-01-23 | Cooperative Research Centre For Tropical Plant Pathology | Anti-microbial protein |
| EP0875564A1 (de) * | 1997-05-02 | 1998-11-04 | Gerard Voerman | Biologisch aktives Extrakt aus den Blutegeln 'Limnatis nilotica' |
| FR2763944B1 (fr) * | 1997-06-03 | 2000-12-15 | Centre Nat Rech Scient | Nouveaux derives de coumarines, leurs procedes de preparation et leur application comme medicaments en tant qu'inhibiteurs de proteases |
| US6232287B1 (en) * | 1998-03-13 | 2001-05-15 | The Burnham Institute | Molecules that home to various selected organs or tissues |
| WO2000056885A1 (de) * | 1999-03-18 | 2000-09-28 | Merck Patent Gmbh | Protein for blocking platelet adhesion |
| CN105592854A (zh) * | 2013-08-05 | 2016-05-18 | 杰拉德·沃尔曼 | 使吸烟的不利作用减少的新方法 |
| EP3193910A1 (de) * | 2014-08-05 | 2017-07-26 | Réunion Therapeutics B.V. | Mutante von blutegelabgeleiteten inhibitoren der neutrophilen elastase und verwendungen davon |
| CN105646702B (zh) * | 2016-04-13 | 2019-03-01 | 中国科学院昆明动物研究所 | 菲牛蛭Kazal型胰蛋白酶抑制剂Bdellin-HM及其编码基因和应用 |
| JP2020531586A (ja) * | 2017-08-27 | 2020-11-05 | アンタイ−ヴァイラル テクノロジーズ， エルエルシー | 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物 |
| US20240207484A1 (en) * | 2021-04-30 | 2024-06-27 | The Regents Of The University Of California | Cartilage treatment for use in eyelid reconstruction |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL86857A (en) * | 1988-06-24 | 1994-04-12 | Yissum Res Dev Co | Platelet-aggregating inhibitory agents from leech saliva and pharmaceutical preparations containing the same |
| US5783421A (en) * | 1993-04-09 | 1998-07-21 | Bio-Technology General Corp. | DNA encoding novel polypeptide having Factor Xa inhibitory activity |
-
1995
- 1995-10-27 CA CA002203827A patent/CA2203827A1/en not_active Abandoned
- 1995-10-27 ES ES95937853T patent/ES2171563T3/es not_active Expired - Lifetime
- 1995-10-27 PT PT95937853T patent/PT789764E/pt unknown
- 1995-10-27 WO PCT/EP1995/004223 patent/WO1996013585A1/en not_active Ceased
- 1995-10-27 AT AT95937853T patent/ATE211765T1/de active
- 1995-10-27 AU AU38701/95A patent/AU3870195A/en not_active Abandoned
- 1995-10-27 EP EP95937853A patent/EP0789764B1/de not_active Expired - Lifetime
- 1995-10-27 DE DE69524971T patent/DE69524971T2/de not_active Expired - Lifetime
- 1995-10-27 JP JP51431496A patent/JP4278175B2/ja not_active Expired - Fee Related
- 1995-10-27 US US08/836,686 patent/US6239106B1/en not_active Expired - Lifetime
- 1995-10-27 DK DK95937853T patent/DK0789764T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| DK0789764T3 (da) | 2002-04-22 |
| US6239106B1 (en) | 2001-05-29 |
| DE69524971D1 (de) | 2002-02-14 |
| ES2171563T3 (es) | 2002-09-16 |
| EP0789764B1 (de) | 2002-01-09 |
| WO1996013585A1 (en) | 1996-05-09 |
| PT789764E (pt) | 2002-06-28 |
| JPH10509589A (ja) | 1998-09-22 |
| DE69524971T2 (de) | 2002-08-29 |
| CA2203827A1 (en) | 1996-05-09 |
| AU3870195A (en) | 1996-05-23 |
| JP4278175B2 (ja) | 2009-06-10 |
| EP0789764A1 (de) | 1997-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE177757T1 (de) | Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17 | |
| FI943591A7 (fi) | Synteettinen hemofilus-influenssa yhdistelmärokote | |
| ATE280826T1 (de) | Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen | |
| ATE419275T1 (de) | Antikörper gegen vla-4 | |
| ATE173478T1 (de) | Varianten des pankreatischen rinder- trypsininhibitors, deren herstellung und verwendung | |
| WO1999015549A3 (en) | Peptide sequences as hinge regions in proteins like immunoglobulin fragments and their use in medicine | |
| NO20061455L (no) | 2,6 dioksopiperidin samt farmasoytiske preparater som inneholder disse | |
| DK0754229T3 (da) | Afamin: et humant serum albumin-lignende protein | |
| EP0422125A4 (en) | Platelet blocking peptides | |
| ATE211765T1 (de) | Neue familie von proteaseinhibitoren und andere biologisch aktive substanzen | |
| ATE331037T1 (de) | Isoliertes frpb nukleinsäuremolekül und entsprechende impfstoff | |
| ATE287963T1 (de) | Pseudomonas exotoxin - myelin basisches protein chimäre proteine | |
| PT830130E (pt) | Enzima de conversao de tnf-alfa | |
| DE68917837D1 (de) | Peptid-Verbindungen. | |
| WO1996018646A3 (en) | Heat shock protein peptides and methods for modulating autoimmune central nervous system disease | |
| FR2692282B1 (fr) | Clonage du gene codant pour la proteine gp28.5 de t. gondii; fragments peptidiques issus de ladite proteine et leurs applications. | |
| FR2624854B1 (fr) | Nouveaux sulfonamides du benzylidene camphre derivant d'aminoacides et leur application en cosmetique, notamment en tant que filtres solaires | |
| EP1251176A3 (de) | Expressionssysteme, die selbstspaltende Fusionsproteine verwenden sowie ein reduzierendes Polypeptid | |
| EP0490383A3 (en) | Peptides of the hiv-gag protein, their preparation and use | |
| TR199700842T1 (xx) | �nsan DNase I Varyantlar�. | |
| NZ228208A (en) | Eglin compounds (hurudin) and protease inhibitor pharmaceutical compositions | |
| KR930004326A (ko) | 콘드로모듈린-ii 단백질 | |
| HUP0001184A2 (hu) | "Basic Helix-Loop-Helix" (bHLH) családba tartozó polipeptidek és a megfelelő nukleinsav-szekvenciák | |
| SE9402253D0 (sv) | Process | |
| ES2059801T3 (es) | Nuevas linfoquinas, secuencias de adn que codifican para estas linfoquinas, y composiciones farmaceuticas conteniendo estas linfoquinas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |